Last 12 months
Inside the activity.
0 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 22 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2019 Filed Jun 3, 2020 20:34 UTC |
Gold Mark StephenDirector
|
GrantRestricted Stock Units · Derivative | 2,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006889 · edgar.xml · derivative · entry 2 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,591 Underlying: Common Stock · 2,591 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| September 03, 2019 Filed Jun 3, 2020 20:34 UTC |
Gold Mark StephenDirector
|
GrantStock Option (right to purchase) · Derivative | 10,710 | $0.00 Strike: $15.44 | $0.00 |
DisclosureSEC source: 0001179110-20-006889 · edgar.xml · derivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,710 Underlying: Common Stock · 10,710 shares Expires 2029-09-03 F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 20:23 UTC |
MARTINEZ MARIA D.Chief Human Resources Officer
|
PurchaseCommon Stock | 2,000 | $15.13 | $30,260.00 |
DisclosureSEC source: 0001179110-19-009511 · edgar.xml · nonDerivative · entry 1 MARTINEZ MARIA D. · CIK 0001633672 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 5 | $15.08 | $75.40 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 13 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,635 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.08 | $1,507.90 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 12 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,630 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.08 | $1,507.90 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 11 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,530 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.08 | $1,507.90 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 10 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,430 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.12 | $1,512.00 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 9 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 200 | $15.11 | $3,022.00 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 8 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,230 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.12 | $1,512.00 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 7 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.11 | $1,511.00 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 6 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,930 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 100 | $15.12 | $1,512.00 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 5 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,830 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 8 | $15.12 | $120.96 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 4 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,730 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 4 | $15.12 | $60.48 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 3 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 88 | $15.12 | $1,330.56 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 2 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,718 Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 20:23 UTC |
Billet IsabelleChief Strategy and BD Officer
|
PurchaseCommon Stock | 4,630 | $15.11 | $69,959.30 |
DisclosureSEC source: 0001179110-19-009512 · edgar.xml · nonDerivative · entry 1 Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,630 Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 12:45 UTC |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 14,170 | $14.10 | $199,797.00 |
DisclosureSEC source: 0001179110-19-009405 · edgar.xml · nonDerivative · entry 3 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,468 Read SEC document |
| August 12, 2019 Filed Jun 5, 2020 20:48 UTC Amendment |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 14,170 | $14.10 | $199,797.00 |
DisclosureSEC source: 0001179110-20-007033 · edgar.xml · nonDerivative · entry 3 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,535 F1 · balance_after: The original Form 4 filed on August 13, 2019 incorrectly stated, in Column 5, the total number of shares beneficially owned by the Reporting Person. This Form 4/A is being filed to correct the error. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 12:59 UTC |
Zaderej Karen L.Director · CEO
|
PurchaseCommon Stock | 75,000 | $13.50 | $1,012,425.00 |
DisclosureSEC source: 0001179110-19-009360 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593,280 Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 12:45 UTC |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 200 | $13.07 | $2,614.00 |
DisclosureSEC source: 0001179110-19-009405 · edgar.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,298 Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 12:45 UTC |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 1,165 | $13.10 | $15,261.50 |
DisclosureSEC source: 0001179110-19-009405 · edgar.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,098 Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 100 | $13.04 | $1,304.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 6 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 348,761 F2 · balance_after: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. F2 · ownership.direct: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 700 | $13.05 | $9,135.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 5 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 348,661 F2 · balance_after: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. F2 · ownership.direct: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 1,000 | $13.13 | $13,130.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 4 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 347,961 F2 · balance_after: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. F2 · ownership.direct: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 100 | $13.04 | $1,304.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 3 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 346,961 F2 · balance_after: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. F2 · ownership.direct: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 100 | $13.04 | $1,304.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 2 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 346,861 F2 · balance_after: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. F2 · ownership.direct: The shares of common stock for Dr. Gold indirect ownership of 2,000 shares held by The Janice Gold Living Trust dated 10-30-17, IA. Read SEC document |
| August 09, 2019 Filed Aug 15, 2019 20:03 UTC |
Gold Mark StephenDirector
|
PurchaseCommon Stock | 2,000 | $13.11 | $26,212.00 |
DisclosureSEC source: 0001179110-19-009535 · edgar.xml · nonDerivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust-See Footnote Disclosed balance after: 346,761 F1 · balance_after: The shares of common stock for Dr. Gold include 49,290 shares held jointly by Dr. Gold and his wife and indirect ownership of 297,471 shares held MJSK, Ltd., a decedent investment trust held by Dr. Gold's Family. F1 · ownership.direct: The shares of common stock for Dr. Gold include 49,290 shares held jointly by Dr. Gold and his wife and indirect ownership of 297,471 shares held MJSK, Ltd., a decedent investment trust held by Dr. Gold's Family. Read SEC document |
| August 09, 2019 Filed Jun 5, 2020 20:48 UTC Amendment |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 200 | $13.07 | $2,614.00 |
DisclosureSEC source: 0001179110-20-007033 · edgar.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 F1 · balance_after: The original Form 4 filed on August 13, 2019 incorrectly stated, in Column 5, the total number of shares beneficially owned by the Reporting Person. This Form 4/A is being filed to correct the error. Read SEC document |
| August 09, 2019 Filed Jun 5, 2020 20:48 UTC Amendment |
Blackford Quentin S.Director
|
PurchaseCommon Stock | 1,165 | $13.10 | $15,261.50 |
DisclosureSEC source: 0001179110-20-007033 · edgar.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,165 F1 · balance_after: The original Form 4 filed on August 13, 2019 incorrectly stated, in Column 5, the total number of shares beneficially owned by the Reporting Person. This Form 4/A is being filed to correct the error. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:34 UTC |
Donovan Michael PatrickVP Operations
|
SaleCommon Stock | 20,000 | $20.00 | $400,000.00 |
DisclosureSEC source: 0001179110-19-007697 · edgar.xml · nonDerivative · entry 1 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,974 F1 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on May 13, 2019. The sales resulted in the completion of the Plan so no more shares will be sold pursuant to the Plan. F2 · price: The price reported is the actual sale price for all of these shares that were sold in multiple transactions. The reporting person undertakes to provide to Axogen, Inc., any security holder of Axogen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the shares. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:31 UTC |
Wendell Amy McBrideDirector
|
PurchaseCommon Stock | 5,000 | $20.25 | $101,250.00 |
DisclosureSEC source: 0001179110-19-007686 · edgar.xml · nonDerivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,333 F1 · shares: The reporting person purchased these shares in her individual capacity in the open market and not through any directed share or other formal program. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.20 to $20.26. The reporting person undertakes to provide to Axogen, Inc., any security holder of Axogen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:07 UTC |
Zaderej Karen L.Director · CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,056 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-19-006887 · edgar.xml · derivative · entry 2 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,056 shares Expires 2019-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:07 UTC |
Zaderej Karen L.Director · CEO
|
Exercise / conversionCommon Stock | 18,056 | $0.27 | $4,875.12 |
DisclosureSEC source: 0001179110-19-006887 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2019 Filed May 18, 2019 01:47 UTC |
Friedman Mark LouisVP,Regulatory & Quality
|
Disposition to issuerCommon Stock | 67,952 | $21.14 | $1,436,593.62 |
DisclosureSEC source: 0001179110-19-006343 · edgar.xml · nonDerivative · entry 1 Friedman Mark Louis · CIK 0001531023 · VP,Regulatory & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560 Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:38 UTC |
Blackford Quentin S.Director
|
GrantStock Option (right to purchase) · Derivative | 23,933 | $0.00 Strike: $22.99 | $0.00 |
DisclosureSEC source: 0001179110-19-006341 · edgar.xml · derivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,933 Underlying: Common Stock · 23,933 shares Expires 2022-05-15 F1 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest annually in equal parts over a three year period and become fully vested on May 15, 2022. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:37 UTC |
Levine Alan MDirector
|
GrantStock Option (right to purchase) · Derivative | 23,933 | $0.00 Strike: $22.99 | $0.00 |
DisclosureSEC source: 0001179110-19-006340 · edgar.xml · derivative · entry 1 Levine Alan M · CIK 0001766833 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,933 Underlying: Common Stock · 23,933 shares Expires 2022-05-15 F1 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest annually in equal parts over a three year period and become fully vested on May 15, 2022. Read SEC document |
| May 13, 2019 Filed May 17, 2019 01:14 UTC |
Hansen David KVP Finance & Treasurer
|
SaleCommon Stock | 20,000 | $22.63 | $452,600.00 |
DisclosureSEC source: 0001104659-19-030080 · a4.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,588 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
Zaderej Karen L.Director · CEO
|
GrantCommon Stock | 16,015 | $17.57 | $281,383.55 |
DisclosureSEC source: 0001179110-19-002059 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,224 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
Freitag Gregory GeneDirector · General Counsel
|
GrantCommon Stock | 3,377 | $17.57 | $59,333.89 |
DisclosureSEC source: 0001179110-19-002058 · edgar.xml · nonDerivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,260 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
Friedman Mark LouisVP,Regulatory & Quality
|
Tax withholdingCommon Stock | 573 | $17.57 | $10,067.61 |
DisclosureSEC source: 0001179110-19-002056 · edgar.xml · nonDerivative · entry 2 Friedman Mark Louis · CIK 0001531023 · VP,Regulatory & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,512 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
Friedman Mark LouisVP,Regulatory & Quality
|
GrantCommon Stock | 1,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002056 · edgar.xml · nonDerivative · entry 1 Friedman Mark Louis · CIK 0001531023 · VP,Regulatory & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,085 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
MARIANI PETER JChief Financial Officer
|
Tax withholdingCommon Stock | 2,355 | $17.57 | $41,377.35 |
DisclosureSEC source: 0001179110-19-002057 · edgar.xml · nonDerivative · entry 2 MARIANI PETER J · CIK 0001222357 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,682 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:25 UTC |
MARIANI PETER JChief Financial Officer
|
GrantCommon Stock | 7,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002057 · edgar.xml · nonDerivative · entry 1 MARIANI PETER J · CIK 0001222357 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,037 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
Donovan Michael PatrickVP Operations
|
Tax withholdingCommon Stock | 573 | $17.57 | $10,067.61 |
DisclosureSEC source: 0001179110-19-002054 · edgar.xml · nonDerivative · entry 2 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,974 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
Donovan Michael PatrickVP Operations
|
GrantCommon Stock | 1,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002054 · edgar.xml · nonDerivative · entry 1 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,547 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
Hansen David KVP Finance & Treasurer
|
Tax withholdingCommon Stock | 573 | $17.57 | $10,067.61 |
DisclosureSEC source: 0001179110-19-002055 · edgar.xml · nonDerivative · entry 2 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,588 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
Hansen David KVP Finance & Treasurer
|
GrantCommon Stock | 1,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002055 · edgar.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,161 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
Tax withholdingCommon Stock | 1,498 | $17.57 | $26,319.86 |
DisclosureSEC source: 0001179110-19-002053 · edgar.xml · nonDerivative · entry 2 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,971 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
GrantCommon Stock | 5,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002053 · edgar.xml · nonDerivative · entry 1 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,469 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC |
Gingrich Jon S.Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,342 | $17.57 | $23,578.94 |
DisclosureSEC source: 0001179110-19-002052 · edgar.xml · nonDerivative · entry 2 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,190 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.